Study Stopped
Adverse Event
Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery
SLIRPS
1 other identifier
interventional
36
1 country
8
Brief Summary
In patients with ulcerative or indeterminate colitis who undergo ileal pouch anal anastomosis and diverting loop ileostomy (IPAA) surgery\* a short interval to loop ileostomy reversal will result in differences in complications and quality of life compared to a long interval to loop ileostomy reversal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Typical duration for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2018
CompletedFirst Posted
Study publicly available on registry
July 16, 2018
CompletedStudy Start
First participant enrolled
November 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedMarch 4, 2022
February 1, 2022
2.3 years
June 26, 2018
February 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Comprehensive Complication Index at 6 months after randomization.
The CCI® calculator is an online tool to support the assessment of patients' overall morbidity. The Comprehensive Complication Index (CCI®) is based on the complication grading by Clavien-Dindo Classification and implements every occurred complication after an intervention. The overall morbidity is reflected on a scale from 0 (no complication) to 100 (death).
6 months
Secondary Outcomes (5)
Total number of postoperative complications per patient
6 months
Percent of patients with complications
1-2 month intervals after randomization through 6 months".
Total number of stoma related complications per patient
1-2 month intervals after randomization through 6 months
Health-related quality of life
Once, at 6 months after ostomy closure surgery
IPAA functional outcomes
Once, at 6 months after ostomy closure surgery
Study Arms (2)
Early ileostomy closure
EXPERIMENTALEarly ileostomy closure will be performed 7 to 12 days after with ileal j-pouch anal anastomosis (IPAA) and loop ileostomy (IPAA).
Late ileostomy closure
ACTIVE COMPARATORLate ileostomy closure will be performed 8 - 12 weeks after IPAA.
Interventions
Eligibility Criteria
You may qualify if:
- Signed informed consents.
- Man or woman between 18 and 64 years of age.
- Ulcerative colitis (UC) or indeterminate colitis (IC) diagnosed by routine clinical, radiographic, endoscopic, and pathological criteria.
- Patient will be scheduled for non-emergent proctocolectomy or completion proctectomy with ileal j-pouch anal anastomosis (IPAA) and loop ileostomy (IPAA).
- Clinical assessment of patient after IPAA surgery indicates that patient is suitable for early ileostomy reversal
You may not qualify if:
- Age \< 18 or \> 64 years
- Colon or rectal cancer
- Crohn's disease or suspected Crohn's disease
- Prednisone dose \> 20 mg per day (or equivalent other steroid dose) within 4 weeks of scheduled IPAA
- Body mass index (BMI) equal to or greater than 40 kg/m2
- Hemodynamic instability (persistent pulse rate \< 50 or \> 120 bpm, systolic blood pressure \< 90 or \> 160 mm Hg, uncontrolled cardiac arrhythmia, or active vasopressor drug use)
- Organ transplant recipient (e.g. Liver, Kidney, Pancreas)
- Immunosuppression due to chemotherapy drug use or systemic disease.
- Sepsis
- Renal insufficiency (i.e. serum creatinine ? 2 mg/dl or need for dialysis)
- Therapeutic anticoagulation (e.g. venous thromboembolic disease, prosthetic heart valve)
- Blood Hemoglobin \< 8 g/dl
- Serum Albumin \< 2.5 g/dl
- Individualized decision by the surgeon to exclude the patient based on sound surgical judgment
- Pregnant patients and female patients who do not satisfy the standard of care requirements of participating centers for an elective surgical procedure.
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Cedars Sinai
Los Angeles, California, 90048, United States
University of Colorado Denver
Aurora, Colorado, 80045, United States
Northwestern University Medical Center
Chicago, Illinois, 60611, United States
University of Chicago
Chicago, Illinois, 60637, United States
Beth Israel
Boston, Massachusetts, 02215, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
Washington University
St Louis, Missouri, 63110, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Related Publications (1)
Vogel JD, Fleshner PR, Holubar SD, Poylin VY, Regenbogen SE, Chapman BC, Messaris E, Mutch MG, Hyman NH. High Complication Rate After Early Ileostomy Closure: Early Termination of the Short Versus Long Interval to Loop Ileostomy Reversal After Pouch Surgery Randomized Trial. Dis Colon Rectum. 2023 Feb 1;66(2):253-261. doi: 10.1097/DCR.0000000000002427. Epub 2023 Jan 6.
PMID: 36627253DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jon Vogel, MD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2018
First Posted
July 16, 2018
Study Start
November 6, 2018
Primary Completion
February 16, 2021
Study Completion
March 31, 2021
Last Updated
March 4, 2022
Record last verified: 2022-02